+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
526445 INDRANIB

Indrayani Biotech Share Price

 

 

Indrayani Biotech live price: ₹10.15. It opened at ₹11 vs previous close ₹11; intraday high/low: ₹11/₹10. The 50 & 200 DMA stand at ₹10.94/₹13.30.

Indrayani Biotech Performance

  • Today's Low
  • ₹10
  • Today's High
  • ₹11
  • 52 Week Low
  • ₹7
  • 52 Week High
  • ₹18
  • Open Price₹11
  • Previous Close₹11
  • Volume63,232
  • 50 DMA₹10.94
  • 100 DMA₹11.18
  • 200 DMA₹13.30

Indrayani Biotech Chart

Investment Returns

  • Over 1 Month -2.68%
  • Over 3 Month + 24.24%
  • Over 6 Month -31.33%
  • Over 1 Year -32.87%

Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!

Invest Now

Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -6.9
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 55
  • P/B Ratio
  • 0.6
  • Average True Range
  • 0.62
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.02
  • RSI
  • 35.85
  • MFI
  • 65.86

Indrayani Biotech Financials

Indrayani Biotech Technicals

EMA & SMA

Current Price
₹10.15
-0.4 (-3.79%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹10.90
  • 50 Day
  • ₹10.90
  • 100 Day
  • ₹11.20
  • 200 Day
  • ₹13.30

Resistance and Support

10.38 Pivot Speed
  • R3 11.57
  • R2 11.23
  • R1 10.72
  • S1 9.87
  • S2 9.53
  • S3 9.02

Indrayani Biotech Shareholding Pattern

33.26%
0%
0%
0%
49%
17.74%

Indrayani Biotech FAQs

Indrayani Biotech share price is ₹10 As on 24 June, 2026 | 07:25

The Market Cap of Indrayani Biotech is ₹54.5 Cr As on 24 June, 2026 | 07:25

The P/E ratio of Indrayani Biotech is -6.9 As on 24 June, 2026 | 07:25

The PB ratio of Indrayani Biotech is 0.6 As on 24 June, 2026 | 07:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23